H. Lee Moffitt Cancer & Research Institute

Tampa, Florida 33612

0 studies enrolling now · 9 studies all time

What they study most

Advanced Solid Tumors, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-small Cell Lung, Carcinoma, Non-small-Cell Lung, Colorectal Cancer, GI Cancer, Hodgkin's Disease, Multiple Myeloma, Neoplasms, Neuroendocrine Carcinoma, Non-small Cell Lung Cancer, Nutritional Deficiency

Studies at this site

• A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer — Recruiting now
• A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer — Running, not enrolling
• A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions — Running, not enrolling
• Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract — Completed
• Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma — Running, not enrolling
• Trial of Dasatinib in Patients With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF Mutation — Stopped early
• Mobile APP Utilization for Enhanced Post-Operative Nutritional Recovery — Completed
• First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C Mutation — Completed
• A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease — Completed